Clinical application of autologous menstrual blood stem cells in the treatment of infertility caused by moderate and severe intrauterine adhesion

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR1900024908

Enrollment

Unknown

Registered

2019-08-03

Start date

2018-01-01

Completion date

Unknown

Last updated

2019-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intrauterine adhesion

Interventions

Case series:Autologous MenSCs intrauterine perfusion

Eligibility

Sex/Gender

Female

Age

22 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. aged 22-40 years; 2. infertility caused by various factors combined with endometrial injury; 3. the damaged endometrium cannot be repaired in the early stage by other treatments, such as hysteroscopy, hormone artificial cycle and traditional Chinese medicine.

Exclusion criteria

Exclusion criteria: 1. over 40 years old; 2. deformity of the reproductive system, such as uterine deformity, infantile uterus and physical diseases unsuitable for pregnancy.

Design outcomes

Primary

Measure	Time frame
endometrial thickness;endometrial morphology;conception rate;Menstrual days;	—

Countries

China

Contacts

Public ContactHai-Lan Ma

Guangxi Guiping People's Hospital

18978551353@189.cn+86 18978551353

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026